Importantly, and consistent with our findings, one of the genes identified by Cohen and colleagues to be differentially marked in CRC compared to normal crypts was FOXQ1. Overexpression of FOXQ1 was previously shown to increase tumor growth in a CRC xenograft mouse model [34]. Here, FOXQ1 is linked to colorectal carcinoma.